Clinical Trial Update: Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports Phase 2 and Phase 3 results evaluating whether a gonadotropin-releasing hormone (GnRH) agonist can prevent chemotherapy-induc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Gonadotropin-releasing hormone agonist

Snippet

Sponsor: Erasme University Hospital | Conditions: Fertility Preservation, Alkylating Agents | Phase 2, Phase 3 | Status: COMPLETED